Martingale Asset Management »

Aurinia Pharmaceuticals shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 106k 16.97
2025-03-31 $99k 12k 8.04

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Facebook Inc cl a (META)
Abbvie (ABBV)
Exxon Mobil Corp
Cisco Systems (CSCO)
Visa (V)
Merck & Co (MRK)

View all positions for Martingale Asset Management

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
Goldman Sachs Group
NEA Management Company
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Marshall Wace
Geode Capital Management
Renaissance Technologies
D. E. Shaw & Co
Vanguard Portfolio Management
Jacobs Levy Equity Management
Caption Management

View all funds holding Aurinia Pharmaceuticals